BTLA is expressed at high levels on tumor-infiltrating Tregs, and its engagement has been associated with upregulation of FOXP3, CD25, and CTLA-4—hallmarks of highly suppressive Treg phenotypes [78]. The gene discussed is BTLA; the disease is neoplasm.